Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Adma Biologics (ADMA) Prices 1.23M Common Offering for Proceeds of $9.8M
-
Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants
-
Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants
-
ADMA Biologics Announces Pricing of Public Offering of Common Stock
-
ADMA Biologics Announces Pricing of Public Offering of Common Stock
-
ALS Data Shows Neuralstem (CUR) Approach is 'Risky' - Maxim Group
-
Arlington Asset Investment Corp. Announces Pricing of Senior Notes Offering
-
21 Listed Companies Participate at Capital Link's 9th Annual International Shipping Forum on Monday, March 23, 2015 -- New York City
-
BioLineRx Closes $28.75 Million Underwritten Public Offering of its American Depositary Shares
-
Arlington Asset Investment Corp. Announces Senior Notes Offering
-
Aeterna Zentaris Announces Closing of US$37 Million Public Offering of Common Shares and Warrants
-
Aeropostale (ARO) Price Target Removed at Maxim Group on Negative EBITDA Trends
-
Gladstone Investment (GAIN) Prices 3.3M Common Offering at $7.40/Share
-
Gladstone Investment Corporation Prices Common Stock Offering
-
Gladstone Investment Corporation Prices Common Stock Offering
-
Opexa Therapeutics Reminds Shareholders That Rights Offering Ownership Date and Time is Tuesday, March 10, 2015 at 4:00 PM ET
-
Gladstone Investment (GAIN) Announces 3M Common Stock Offering
-
Gladstone Investment Corporation Announces Common Stock Offering
-
Gladstone Investment Corporation Announces Common Stock Offering
-
REMINDER - 21 Listed Companies Participate at Capital Link's 9th Annual International Shipping Forum on Monday, March 23, 2015 -- New York City
-
BioLineRx (BLRX) Prices 12.5M Public Offering at $2/ADS
-
BioLineRx Prices $25 Million Underwritten Public Offering of its American Depositary Shares
-
Aeterna Zentaris Announces Pricing of US$37 Million Public Offering of Common Shares and Warrants
-
Genetic Technologies (GENE) Raises AUD$18.6 Million in Capital
-
Keryx Biopharmaceuticals (KERX) Bullish Stance Reiterated at Maxim Group Following Auryxia Publications
-
Macy's (M) PT Lifted to $60 at Maxim Group
-
Kohl's (KSS) PT, Estimates Raised at Maxim Group
-
Omeros Corp. (OMER) PT Raised to $30 at Maxim Group
-
Maxim Group Downgrades The Children's Place (PLCE) to Hold
-
Achillion Pharmaceuticals (ACHN) Data Good, But Expected - Maxim Group
-
Trovagene (TROV) Prices 4.44M Common Offering for Proceeds of ~$20M
-
Ziopharm Oncology (ZIOP) Prices 10M COmmon Offering at $8.75/Share
-
Maxim Group Upgrades CACI International (CACI) to Buy (Earlier)
-
Maxim Group Downgrades Vertex (VRTX) to Hold
-
Auspex Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Maxim Group Upgrades NIC Inc. (EGOV) to Hold
-
Athersys (ATHX) PT Lifted to $9 at Maxim Group
-
Auspex Pharmaceuticals (ASPX) Prices 4M Common Follo-On at $56.50/Share
-
Auspex Announces Pricing of Follow on Offering
-
Maxim Group Downgrades Momenta Pharmaceuticals (MNTA) to Sell
-
Keryx Biopharma (KERX) Prices 9.17M Common Offering at $12/Share
-
Keryx Biopharmaceuticals, Inc. Announces Pricing of $110 Million Public Offering of Common Stock
-
Oculus Innovative Sciences (OCLS) Prices 6.25M Common, 4.7M Warrants Offering at $1/Share
-
Brainstorm Cell Therapeutics (BCLI) Bullish Stance Reiterated at Maxim Group Following Capital Raise
-
Sucampo Pharmaceuticals (SCMP) PT Raised to $19 at Maxim Group
-
SNB Decision Could Impact Some U.S. Retailers, Maxim Group Says (RL) (KORS)
-
Adamis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in Full
-
Maxim Group Starts Applied DNA Sciences (APDN) at Buy
-
Tekmira Pharma (TKMR) PT Lifted to $27 at Maxim Group on Merger
-
Agenus (AGEN) PT Raised to $11 at Maxim Group Amid Incyte Deal

